149 related articles for article (PubMed ID: 17571254)
21. Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus.
Kovarik JM; Noe A; Wang Y; Mueller I; DeNucci G; Schmouder RL
Eur J Clin Pharmacol; 2006 May; 62(5):361-6. PubMed ID: 16547714
[TBL] [Abstract][Full Text] [Related]
22. Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® EL.
Ehinger KH; Hansson MJ; Sjövall F; Elmér E
Clin Drug Investig; 2013 Jan; 33(1):25-34. PubMed ID: 23179472
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients.
Hibberd AD; Trevillian PR; Roger SD; Wlodarczyk JH; Stein AM; Bohringer EG; Milson-Hawke SM
Transplantation; 2006 Mar; 81(5):711-7. PubMed ID: 16534473
[TBL] [Abstract][Full Text] [Related]
24. Effect of food on everolimus absorption: quantification in healthy subjects and a confirmatory screening in patients with renal transplants.
Kovarik JM; Hartmann S; Figueiredo J; Rordorf C; Golor G; Lison A; Budde K; Neumayer HH
Pharmacotherapy; 2002 Feb; 22(2):154-9. PubMed ID: 11837553
[TBL] [Abstract][Full Text] [Related]
25. Bioequivalence of a new cyclosporine a formulation to Neoral.
David-Neto E; Kakehashi E; Alves CF; Pereira LM; de Castro MC; de Mattos RM; Sumita NM; Romano P; Mendes ME; Nahas WC; Ianhez LE
Ther Drug Monit; 2004 Feb; 26(1):53-7. PubMed ID: 14749551
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two microemulsion of cyclosporine A in healthy volunteers.
Tanasescu C; Serbanescu A; Spadaro A; Jen LH; Oliani C
Eur Rev Med Pharmacol Sci; 1999; 3(1):5-9. PubMed ID: 10710823
[TBL] [Abstract][Full Text] [Related]
27. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics, efficacy, and safety of Iminoral compared with Neoral in healthy volunteers and renal transplant recipients.
Sayyah M; Argani H; Pourmand GR; Amini H; Ahmadiani A
Transplant Proc; 2007 May; 39(4):1214-8. PubMed ID: 17524936
[TBL] [Abstract][Full Text] [Related]
29. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
30. Bioavailability of Sandimmun® versus Sandimmun Neoral®: a meta-analysis of published studies.
Colombo D; Egan CG
Int J Immunopathol Pharmacol; 2010; 23(4):1177-83. PubMed ID: 21244766
[TBL] [Abstract][Full Text] [Related]
31. Bioequivalence study of Cipol-N (cyclosporine microemulsion preparation) in healthy adults.
Park MS; Yu NC; Kim YS; Lee HK; Kim KH
Transplant Proc; 1998 Nov; 30(7):3541-6. PubMed ID: 9838551
[No Abstract] [Full Text] [Related]
32. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of pregabalin controlled-release in healthy volunteers: effect of food in five single-dose, randomized, clinical pharmacology studies.
Chew ML; Plotka A; Alvey CW; Pitman VW; Alebic-Kolbah T; Scavone JM; Bockbrader HN
Clin Drug Investig; 2014 Sep; 34(9):617-26. PubMed ID: 25078976
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
35. Sex- and smoke-related differences in gastrointestinal transit of cyclosporin A microemulsion capsules.
Fagiolino P; Vázquez M; Ibarra M; Magallanes L; Guevara N; Fotaki N
Eur J Pharm Sci; 2014 Oct; 63():140-6. PubMed ID: 25051348
[TBL] [Abstract][Full Text] [Related]
36. Administration diluents differentiate Neoral from a generic cyclosporine oral solution.
Kovarik JM; Barilla D; McMahon L; Wang Y; Kisicki J; Schmouder R
Clin Transplant; 2002 Aug; 16(4):306-9. PubMed ID: 12099989
[TBL] [Abstract][Full Text] [Related]
37. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
[TBL] [Abstract][Full Text] [Related]
38. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
Godfrey AR; Digiacinto J; Davis MW
Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
[TBL] [Abstract][Full Text] [Related]
39. The effect of a high-fat meal on the oral bioavailability of the immunosuppressant sirolimus (rapamycin).
Zimmerman JJ; Ferron GM; Lim HK; Parker V
J Clin Pharmacol; 1999 Nov; 39(11):1155-61. PubMed ID: 10579146
[TBL] [Abstract][Full Text] [Related]
40. Switchability of neoral and equoral according to Food and Drug Administration rules and regulations.
Masri MA; Haberal M; Rizvi A; Stephan A; Bilgin N; Naqvi A; Barbari A; Kamel G; Zafar N; Emiroğlu R; Colak T; Manzoor K; Matha V; Kamarad V; Rost M; Rizk S; Hazime A; Perlik F
Transplant Proc; 2005 Sep; 37(7):2988-93. PubMed ID: 16213282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
